Physician profile
Ilya A Volfson
NPI 1336181205
$3,291.79
in general payments reported to CMS, 2019-2025
36 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $403 · 2021: $259 · 2022: $231 · 2023: $294 · 2024: $275 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $771.39 | 2021-2025 | Barrigel, Urolift |
| Medtronic, INC. | $386.04 | 2025 | Altaviva, Interstim |
| Musculoskeletal Transplant Foundation INC. | $347.26 | 2019-2020 | |
| Telix Pharmaceuticals | $167.92 | 2024-2025 | Illuccix |
| Smith+Nephew, INC. | $156.76 | 2019-2025 | Stravix Pl, Stravix |
| Blue Earth Diagnostics | $130.98 | 2019-2025 | Posluma |
| Calyxo, INC. | $105.82 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $98.49 | 2023-2025 | Orgovyx |
| Intuitive Surgical, INC. | $97.88 | 2025 | |
| Astellas Pharma US INC | $97.65 | 2019-2023 | Xtandi, Myrbetriq |
| Progenics Pharmaceuticals, INC. | $92.44 | 2022-2024 | Pylarify |
| Abbvie INC. | $87.80 | 2024-2025 | |
| Urogen Pharma, INC. | $80.48 | 2021-2025 | Jelmyto |
| Ambu INC. | $75.61 | 2023-2024 | |
| Neotract INC. | $61.31 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $52.72 | 2025 | |
| Janssen Biotech, INC. | $50.74 | 2019-2021 | |
| Boston Scientific Corporation | $44.49 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $32.55 | 2025 | Provenge |
| Endo USA, INC. | $32.14 | 2025 | Xiaflex, Aveed |
| Bioprotect Medical, INC. | $31.07 | 2025 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $30.11 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $28.30 | 2025 | |
| Olympus America INC. | $22.64 | 2024 | Itind System |
| Procept Biorobotics Corporation | $21.14 | 2024 | Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $20.23 | 2020 | |
| Sun Pharmaceutical Industries INC. | $19.94 | 2022 | |
| Innovation Technologies INC | $19.75 | 2024 | Irrisept |
| Pfizer INC. | $18.03 | 2023 | |
| Coloplast Corp | $17.41 | 2025 | |
| Myovant Sciences INC. | $17.41 | 2022 | |
| Accord Healthcare, INC. | $17.27 | 2022 | |
| Endo Pharmaceuticals INC. | $16.73 | 2019 | |
| Cook Medical LLC | $14.55 | 2025 | Cook |
| Verity Pharmaceuticals INC. | $14.01 | 2022 | |
| Acerus Pharmaceuticals Corporation | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Volfson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.